Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Sells $36,455,577.60 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 5,842,240 shares of Aveanna Healthcare stock in a transaction on Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total transaction of $36,455,577.60. Following the transaction, the insider directly owned 13,450,547 shares of the company’s stock, valued at $83,931,413.28. This represents a 30.28% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Aveanna Healthcare Stock Performance

Shares of AVAH opened at $6.68 on Monday. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 5.35. The firm’s fifty day simple moving average is $6.79 and its two-hundred day simple moving average is $7.71. Aveanna Healthcare Holdings Inc. has a 12 month low of $3.73 and a 12 month high of $10.32. The stock has a market capitalization of $1.45 billion, a P/E ratio of 5.66, a price-to-earnings-growth ratio of 0.75 and a beta of 1.93.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.13 by $0.05. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The company had revenue of $647.92 million for the quarter, compared to the consensus estimate of $613.22 million. The firm’s quarterly revenue was up 15.9% compared to the same quarter last year. As a group, analysts predict that Aveanna Healthcare Holdings Inc. will post 0.6 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Caitong International Asset Management Co. Ltd grew its holdings in Aveanna Healthcare by 252.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after buying an additional 2,400 shares in the last quarter. Quantbot Technologies LP bought a new position in Aveanna Healthcare during the 2nd quarter valued at $43,000. Summit Securities Group LLC purchased a new position in Aveanna Healthcare during the 1st quarter worth $53,000. Oxford Asset Management LLP purchased a new position in Aveanna Healthcare during the 2nd quarter worth $64,000. Finally, Bayesian Capital Management LP bought a new stake in shares of Aveanna Healthcare in the 2nd quarter worth $85,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Truist Financial increased their price target on Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a report on Wednesday, May 20th. Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $10.00 to $11.00 in a research note on Friday, May 15th. BMO Capital Markets dropped their target price on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Friday, March 20th. Barclays reduced their price target on shares of Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating for the company in a report on Monday, May 18th. Finally, Raymond James Financial raised shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price target for the company in a research note on Friday, March 20th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $10.50.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.